More about OTC25 Jul 2020 19:36
There is at least a theoretical advantage to trading OTC in USA from UK, by exploiting time difference and UK bank holidays. I have tried this once with a UK listed company on a bank holiday when there was at a skeleton staff at my broker office (it was RBS at the time).
A late RNS on Friday looked negative so I called the broker on bank holiday Monday and asked him to put a sell order via OTC in NY which he was able to do. I thought I was getting ahead of the curve before the SP tanked on Tuesday! It’s a matched trade process and if no one takes your offer, it closes that day. No-one took my offer, because they knew what I knew even 3000 miles away!
Foreign companies cannot trade their shares on US markets by law. They either trade American Depositary Receipts (ADR) which are derivative instruments with the same value as a share, or they use the OTC market, which is not a stock exchange, but an over the counter platform for matched trades where a broker takes a commission. I can sell my shares to a bloke in Miami, if he agrees to buy them and vice versa. There is no liquidity provided by “jobbers” as they used to be called. There is some repatriation of shares when the opposite process takes place. However the shares being traded are the same shares as those on LSE.
42 UK companies trade ADRs in USA, 193 main market UK companies trade on OTC , and Lord knows how many AIM stocks do.
Last OTC trade after hours on Friday for ticker SYGGF according to Google was $3.05, but the official OTC Market website says a $3.30 close. Either way, well above £2.
Not sure how valuable OTC moves are, but the Guardian article was published at 4.30 pm on Friday. Surely intended not to influence LSE but maybe influenced OTC across the pond?